Inventor · disambiguated record
Morgan Maeder
Also filed as: MAEDER MORGAN · MAEDER MORGAN L · MAEDER MORGAN LEE
29 granted patents·22 pending applications·536 citations·filing 2010–2025
97Inventor score
Files withEDITAS MEDICINE INC23MASSACHUSETTS GEN HOSPITAL19MASSACHUSETTS EYE & EAR INFIRMARY2NCHROMA BIO INC2CHROMA MEDICINE INC1
Top patents by PatentIndex Score
51 records- 0198US11168338B2RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic lociMASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Nov 9, 2021·17 cites·10 claims
- 0298US10844403B2Increasing specificity for RNA-guided genome editingMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Nov 24, 2020·31 cites·30 claims
- 0398US9885033B2Increasing specificity for RNA-guided genome editingMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Feb 6, 2018·95 cites·3 claims
- 0497US10760064B2RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic lociMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Sep 1, 2020·38 cites·20 claims
- 0597US10415059B2Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editingMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Sep 17, 2019·43 cites·31 claims
- 0697US10378027B2RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic lociMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Aug 13, 2019·18 cites·11 claims
- 0797US10119133B2Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editingMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Nov 6, 2018·39 cites·11 claims
- 0897US9567604B2Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editingMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Feb 14, 2017·87 cites·17 claims
- 0995US11634731B2Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editingMASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Apr 25, 2023·6 cites·19 claims
- 1095US10253312B2CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)EDITAS MEDICINE INC·Filed 2018·Granted Apr 9, 2019·13 cites·29 claims
- 1194US9938521B2CRISPR/CAS-related methods and compositions for treating leber's congenital amaurosis 10 (LCA10)EDITAS MEDICINE INC·Filed 2015·Granted Apr 10, 2018·12 cites·39 claims
- 1294US8846578B2Zinc finger nuclease for the CFTR gene and methods of use thereofMCCRAY PAUL·Filed 2010·Granted Sep 30, 2014·93 cites·15 claims
- 1393US12234449B2CRISPR/Cas-related methods and compositions for treating Leber's congenital amaurosis 10 (LCA10)EDITAS MEDICINE INC·Filed 2022·Granted Feb 25, 2025·1 cites·17 claims
- 1493US9890364B2TAL-Tet1 fusion proteins and methods of use thereofMASSACHUSETTS GEN HOSPITAL·Filed 2013·Granted Feb 13, 2018·18 cites·10 claims
- 1593US2025034597A1RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic LociMASSACHUSETTS GEN HOSPITAL·Filed 2024·Application pending·0 cites
- 1692US11028388B2CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosaEDITAS MEDICINE INC·Filed 2015·Granted Jun 8, 2021·7 cites·22 claims
- 1790US11268086B2CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)EDITAS MEDICINE INC·Filed 2019·Granted Mar 8, 2022·3 cites·41 claims
- 1887US10676749B2Tale transcriptional activatorsMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Jun 9, 2020·2 cites·20 claims
- 1987US2023407341A1Using Truncated Guide RNAs (tru-gRNAs) to Increase Specificity for RNA-Guided Genome EditingMASSACHUSETTS GEN HOSPITAL·Filed 2023·Application pending·0 cites
- 2086US10894950B2TAL-Tet1 fusion proteins and methods of use thereofMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Jan 19, 2021·2 cites·14 claims
- 2186US2025115884A1TAL-Tet1 Fusion Proteins and Methods of Use ThereofMASSACHUSETTS GEN HOSPITAL·Filed 2024·Application pending·0 cites
- 2285US11339437B2Compositions and methods for treating CEP290-associated diseaseEDITAS MEDICINE INC·Filed 2017·Granted May 24, 2022·3 cites·117 claims
- 2384US11566263B2Compositions and methods for treating CEP290 associated diseaseEDITAS MEDICINE INC·Filed 2017·Granted Jan 31, 2023·3 cites·28 claims
- 2483US12065668B2RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic lociMASSACHUSETTS GEN HOSPITAL·Filed 2021·Granted Aug 20, 2024·0 cites·7 claims
- 2582US11242525B2CRISPR/CAS-related methods and compositions for treating sickle cell diseaseEDITAS MEDICINE INC·Filed 2015·Granted Feb 8, 2022·2 cites·28 claims
- 2680US11806408B2Methods and compositions for treating cone-rod retinal dystrophyUNIV FLORIDA·Filed 2018·Granted Nov 7, 2023·1 cites·15 claims
- 2778US11141493B2Compositions and methods for treating CEP290-associated diseaseEDITAS MEDICINE INC·Filed 2018·Granted Oct 12, 2021·2 cites·35 claims
- 2875US12152254B2TAL-Tet1 fusion proteins and methods of use thereofMASSACHUSETTS GEN HOSPITAL·Filed 2021·Granted Nov 26, 2024·0 cites·9 claims
- 2975US2024294917A1Crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1)EDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 3070US2024141386A1Compositions and methods for treating cep290 associated diseaseEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 3168US2020354704A1RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic LociMASSACHUSETTS GEN HOSPITAL·Filed 2020·Application pending·0 cites
- 3268US2022273818A1Compositions and methods for treating cep290-associated diseaseEDITAS MEDICINE INC·Filed 2021·Application pending·0 cites
- 3368US2023026726A1Crispr/cas-related methods and compositions for treating sickle cell diseaseEDITAS MEDICINE INC·Filed 2022·Application pending·0 cites
- 3468US2023295725A1Compositions and methods for treating cep290-associated diseaseEDITAS MEDICINE INC·Filed 2022·Application pending·0 cites
- 3564US2022106600A1Crispr-cas-related methods, compositions and components for cancer immunotherapyEDITAS MEDICINE INC·Filed 2021·Application pending·0 cites
- 3663US2024076678A1Compositions and methods for epigenetic editingCHROMA MEDICINE INC·Filed 2023·Application pending·0 cites
- 3762US2025346875A1CRISPR/Cas9-Mediated Exon-Skipping Approach for USH2A-Associated Usher SyndromeMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2025·Application pending·0 cites
- 3862US2021380987A1Crispr/cas-related methods and compositions for treating cystic fibrosisEDITAS MEDICINE INC·Filed 2021·Application pending·0 cites
- 3961US10731167B2Tale transcriptional activatorsMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Aug 4, 2020·0 cites·15 claims
- 4059US12331328B2CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated usher syndromeMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2019·Granted Jun 17, 2025·0 cites·17 claims
- 4157US2025387514A1Compositions and methods for epigenetic regulation of trac expressionNCHROMA BIO INC·Filed 2023·Application pending·0 cites
- 4257US2025387518A1Compositions and methods for epigenetic regulation of b2m expressionNCHROMA BIO INC·Filed 2023·Application pending·0 cites
- 4355US2023038993A1Compositions and methods for treating cep290-associated diseaseEDITAS MEDICINE INC·Filed 2021·Application pending·0 cites
- 4454US11028394B2CRISPR/CAS-related methods and compositions for treating cystic fibrosisEDITAS MEDICINE INC·Filed 2016·Granted Jun 8, 2021·0 cites·9 claims
- 4552US2015093802A1Zinc finger nuclease for the cftr gene and methods of use thereofGEN HOSPITAL CORP·Filed 2014·Application pending·0 cites
- 4651US2017073685A1Crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1)EDITAS MEDICINE INC·Filed 2016·Application pending·0 cites
- 4747US2017175128A1Crispr-cas-related methods, compositions and components for cancer immunotherapyEDITAS MEDICINE INC·Filed 2015·Application pending·0 cites
- 4843US12460231B2Crispr/CAS-related methods and compositions for treating primary open angle glaucomaEDITAS MEDICINE INC·Filed 2015·Granted Nov 4, 2025·0 cites·11 claims
- 4941US2017007679A1Crispr/cas-related methods and compositions for treating hiv infection and aidsEDITAS MEDICINE INC·Filed 2016·Application pending·0 cites
- 5037US2019136230A1Genetically engineered cells and methods of making the sameJUNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →